Диссертация (1139940), страница 20
Текст из файла (страница 20)
Colour duplex sonography of temporal arteries before decision forbiopsy: a prospective study in 55 patients with suspected giant cell arteritis. //Arthritis Res Ther, 2006, 32, No. 8, P. 116.58. Loffler C., Hoffend J., Benck U., Kramer B., Bergner R. The value ofultrasound in diagnosing extracranial large-vessel vasculitis compared to FDGPET/CT: a retrospective study. // Clin Rheumatol, 2017, doi: 10.1007/s10067-0173669-7.13259.MontiS., FlorisA., PonteC., SchmidtW.A., DiamantopoulosA.P., Pereira C., et al. The use of ultrasound to assess giant cell arteritis: review ofthe current evidence and practical guide for the rheumatologist. // Rheumatology(Oxford), 2017, doi: 10.1093/rheumatology/kex173.60.
Aschwanden M., Daikeler T., Kesten F., Baldi T., Benz D., Tyndall A.,et.al. Temporal artery compressions sign a novel ultrasound finding for thediagnosis of giant cell arteritis. // Ultraschall Med, 2013, 34, No. 1, P. 47-50.61. Cimmino M., Camellino D. Large vessel vasculitis: which imagingmethod? // Swiss Med Wkly, 2017, 21, No.147, w14405, doi: smw.2017.14405.62. Akter F., Ward K. Large-vessel GCA or a late presentation of Takayasu’sarteritis? // BMJ Case Rep, 2012, doi:10.1136/bcr.03.2012.5995.63.
Litmanovich D., Yıldırım A., Bankier A. Insights into imaging of aortitis. //Insights Imaging, 2012, 3, No. 6, P. 545–60.64. Yamada I., Nakagawa T., Himeno Y., Numano F., Shibuya H. Takayasuarteritis: evaluation of the thoracic aorta with CT angiography. // Radiology, 1998,209, No. 1, P. 103-9.65. Saam T., Habs M., Cyran C., Grimm J., Pfefferkorn T., Schüller U., et all.New aspects of MRI for diagnostics of large vessel vasculitis and primary angiitis ofthe central nervous system. // Radiologe, 2010, 50, No.10, P.
861-71.66. Yamada I., Nakagawa T., Himeno Y., Kobayashi Y., Numano F., ShibuyaH. Takayasu arteritis: diagnosis with breath-hold contrast-enhanced threedimensional MR angiography. // J Magn Reson Imaging, 2000, 11, No. 5, P. 481-7.67. Gračanin A., Ćurić J., Lončarević J., Morović-Vergles J. Magneticresonance imaging in the diagnosis and follow-up of giant cell arteritis: case reportand review of literature. // Eur J Rheumatol, 2015, 2, No.3, P.125-4.68. Zerizer I., Tana K., Khana S., Barwicka T., Marzolab M., Rubellob D.Role of FDG-PET and PET/CT in the diagnosis and management of vasculitis. //Eur J Radiol, 2010, 73, No. 2, P. 504 – 9.13369.Лишманов Ю.Б.
Национальное руководство по радионуклиднойдиагностике // Ю.Б. Лишманов, В.И. Чернов, А.А. Балабанова и соавт. –Томск: 2010, том 2. – 295-315 с.70. Wu C., Li F., Niu G., Chen X. PЕТ imaging of inflammation biomarkers.// Theranostics, 2013, 3, No. 7, P. 448-66.71. Мухортова О.В. Клиническое применение позитронно-эмиссионнойтомографии в диагностике злокачественных лимфом, рака молочной железы ирака легкого: Диссертация доктора медицинских наук: 14.01.13 // Обнинск,2011. – 364 с.72.
Belhocine T., Blockmans D., Hustinx R., Vandevivere J., Mortelmans L.Imaging of large vessel vasculitis with 18FDG PET: illusion or reality? A criticalreview of the literature data. // Eur J Nucl Med Mol Imaging, 2003, 30, No. 9, P.1305 – 13.73. Papathanasiou N., Du Y., Menezes L., Almuhaideb A., Shastry M., BeynonH., et al. 18F-Fludeoxyglucose PET/CT in the evaluation of large-vessel vasculitis:diagnostic performance and correlation with clinical and laboratory parameters. //British J Radiol, 2012, 85, P. 188-194.74. Danve A., O’Dell J. The role of 18F Fluorodeoxyglucose positronemission tomography scanning in the diagnosis and management of systemicvasculitis.
// Int J Rheum Dis, 2015, 18, No. 7, P. 714-24.75. Balink H., Bennink R., Veeger N., van Eck-Smit B., Verberne H.Diagnostic utility of 18F-FDG PET/CT in inflammation of unknown origin. // ClinNucl Med, 2014, 39, No.5, P. 419-25.76. Lensen K., Voskuyl A., van der Laken C., Comans E., van SchaardenburgD., Arntzenius A. 18F-Fluorodeoxyglucose positron emission tomography in elderlypatients with an elevated erythrocyte sedimentation rate of unknown origin. // PLoSOne, 2013, 8, No. 3, e58917.13477. Yamashita H., Kubota K., Mimori A. Clinical value of whole-bodyPET/CT in patients with active rheumatic diseases. // Arthritis Res Ther, 2014, 16,No.
5, P. 423-12.78. Adams H., Raijmakers P., Smulders Y. Polymyalgia rheumatica andinterspinous FDG uptake on PET/CT. // Clin Nucl Med, 2012, 37, No. 5, P. 502-5.79. Ostberg G. An arteritis with special reference to polymyalgia arteritica. //Acta Pathol Microbiol Scand, 1973, 237, P. 1-59.80. Blockmans D.
PET in vasculitis. // Ann. N Y Acad Sci, 2011, 1228, P. 6470.81. Hernandez-Rodriguez J., Font C., Garcia-Martinez A., Espigol-FrigoleG., Sanmarti R., Canete J., et al. Development of ischemic complications in patientswith giant cell arteritis presenting with apparently isolated polymyalgia rheumatica:study of a series of 100 patients. Medicine (Baltimore), 2007, 86, No. 4, P.
233-41.82. Bartels A., Zeebregts C., Bijl M., Tio R., Slart R. Fused FDG-PET andMRI imaging of Takayasu arteritis in vertebral arteries. // Ann Nucl Med, 2009, 23,No. 8, P. 753-6.83. Blockmans D., Stroobants S., Maes A., Mortelmans L. Positron emissiontomography in giant cell arteritis and polymyalgia rheumatica: evidence forinflammation of the aortic arch. // Am J Med, 2000, 108, No. 3, P. 246-9.84. Henes J., Mueller M., Pfannenberg C., Kanz L., Koetter I.Cyclophosphamide for large vessel vasculitis: assessment of response by PET/CT.
//Clin Exp Rheumatol, 2011, 29, No. 1, P. 43-8.85. Hooisma G., Balink H., Houtman P., Slart R., Lensen K. Parametersrelated to a positive test result for FDG PET(/CT) for large vessel vasculitis: amulticenter retrospective study. // Clin Rheumatol, 2012, 31, No. 5, P. 861-71.86. Bucerius J., Mani V., Moncrieff C., Machac J., Fuster V., Farkouh M., etal. Optimizing 18F-FDG PET/CT imaging of vessel wall inflammation: the impact135of 18F-FDG circulation time, injected dose, uptake parameters, and fasting bloodglucose levels. // Eur J Nucl Med Mol Imaging, 2014, 41, No.
2, P. 369-83.87. Blomberg B., Thomassen A., Takx R., Hildebrandt M., Simonsen J., BuchOlsen K., et al. Delayed 18F-fluorodeoxyglucose PET/CT imaging improvesquantitation of atherosclerotic plaque inflammation: results from the CAMONAstudy. // J Nucl Cardiol, 2014, 21, No. 3, P. 588-97.88. Siczek K., Faggioli P., Venegoni E., Florimonte L., Cammelli F., VignatiA., et all.
Role of 18F-FDG PET/CT in vasculitis: a prospective study. // IBIMAPublishing, 2014, Article ID 389734, P. 13.89. Castellanosa M., Minguez Vega M., Caballeroa A., Bernabeu GonzálvezaM. Early diagnosis of large vessel vasculitis: usefulness of positron emissiontomography with computed tomography. // Reumatol Clin, 2013, 9, No. 1, P. 65-8.90. Lehmann P., Buchtala S., Achajew N., Haerle P., Ehrenstein B., LighvaniH., et al. 18F-FDG PET as a diagnostic procedure in large vessel vasculitis – acontrolled, blinded reexamination of routine PET scans. // Clin Rheumatol, 2011,30, No. 1, P. 37-42.91.
Samejima K., Nakatani K., Sioyama M., Kinoshita K., Kinoshita S., SaitoY. et al. Case of temporal arteritis: FDP-PET (18F-fluorodeoxyglucose – positronemission tomography) was useful for early diagnosis and treatment. // ainon RinshoMeneki Gakkai Kaishi, 2010, 33, No. 6, P. 324–328.92. Tarkin J., Rudd J. Techniques for noninvasive molecular imaging ofatherosclerotic plaque.
// Nat Rev Cardiol, 2014, 12, No. 2, P. 79.93. Santanam N., Thornhill B., Lau J., Crabtree C., Cook C., Brown K., et al.Nicotinic acetylcholine receptor signaling in atherogenesis. // Atherosclerosis, 2012,225, No. 2, P. 264-73.94. Clinton S., Underwood R., Hayes L., Sherman M., Kufe D., Libby P.Macrophage colony-stimulating factor gene expression in vascular cells and in136experimental and human atherosclerosis. // Am J Pathol, 1992, 140, No. 2, P.
30116.95. Joseph P., Tawakol A. Imaging atherosclerosis with positron emissiontomography. // Eur Heart J, 2016, 37, No. 39, P. 2974-2980.96. Soussan M., Nicolas P., Schramm C., Katsanian S., Pop G., Fain O., et al.Management of large-vessel vasculitis with FDG-PET. // Medicine, 2015, 94, No.14, P.
622-8.97. Glaudemans A., Signore A. FDG-PET/CT in infections: the imagingmethod of choice? // Eur J Nucl Med Mol Imaging, 2010, 37, No. 10, P. 1986-91.98. Bertagna F., Bosio G., Caobelli F., Motta F., Biasiotto G., Giubbini R.Roleof18F-fluorodeoxyglucosepositronemissiontomography/computedtomography for therapy evaluation of patients with large-vessel vasculitis. // Jpn JRadiol, 2010, 28, No. 3, P. 199-204.99. Tezuka D., Haraguchi G., Ishihara T., Ohigashi H., InagakiH., Suzuki J.,et all. Role of FDG PET-CT in Takayasu arteritis: sensitive detection ofrecurrences.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
